Acelrx pharmaceuticals alert: bragar eagel & squire, p.c. announces that a class action lawsuit has been filed against acelrx pharmaceuticals, inc. and encourages investors to contact the firm

New york--(business wire)-- #acelrx--bragar eagel & squire, p.c., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the united states district court for the northern district of california on behalf of investors that purchased acelrx pharmaceuticals, inc. (nasdaq: acrx) securities between march 17, 2020 and february 12, 2021, both dates inclusive (the “class period”). investors have until august 9, 2021 to apply to the court to be appointed a
ACRX Ratings Summary
ACRX Quant Ranking